Doxecitine and doxribtimine for the treatment of TK2 deficiency: FDA approval summary

Molecular Genetics and Metabolism 2026

View at publisher
Authors: Daniela V. Luquetti, Wonyul Lee
DOI: 10.1016/j.ymgme.2026.109735
Cited by: 0
References: 1

Fields of Study & Subjects

Metabolism and Genetic Disorders Biochemical and Molecular Research Lysosomal Storage Disorders Research

Publication details

Journal / source
Molecular Genetics and Metabolism
Volume
147
Issue
3
Pages
109735–109735
Publication date
12 February 2026
Language
EN